Enovix Co. (NASDAQ:ENVX – Get Free Report)’s stock price dropped 4.6% during trading on Thursday . The stock traded as low as $10.95 and last traded at $10.91. Approximately 497,018 shares traded hands during trading, a decline of 94% from the average daily volume of 7,831,504 shares. The stock had previously closed at $11.44.
Analyst Ratings Changes
Several equities analysts recently commented on the company. Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Benchmark reaffirmed a “buy” rating and set a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Enovix has an average rating of “Moderate Buy” and an average price target of $20.50.
Check Out Our Latest Analysis on ENVX
Enovix Trading Up 1.7 %
Enovix (NASDAQ:ENVX – Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.20) by $0.03. The company had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same quarter last year, the firm earned ($0.27) EPS. As a group, analysts anticipate that Enovix Co. will post -1.17 EPS for the current year.
Insider Buying and Selling at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the transaction, the director now directly owns 99,497 shares in the company, valued at $968,105.81. The trade was a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 15.70% of the stock is owned by insiders.
Institutional Trading of Enovix
Hedge funds have recently made changes to their positions in the stock. Prospera Private Wealth LLC acquired a new stake in Enovix in the third quarter worth $27,000. Fifth Third Bancorp increased its holdings in shares of Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock worth $27,000 after acquiring an additional 1,000 shares during the period. Strategic Investment Solutions Inc. IL bought a new stake in Enovix in the 2nd quarter valued at about $39,000. R Squared Ltd acquired a new position in Enovix during the 4th quarter valued at about $64,000. Finally, Voisard Asset Management Group Inc. grew its position in Enovix by 40.0% in the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock worth $65,000 after purchasing an additional 2,000 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Recommended Stories
- Five stocks we like better than Enovix
- The 3 Best Blue-Chip Stocks to Buy Now
- Bloom Energy: Powering the Future With Decentralized Energy
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Invest in Small Cap StocksĀ
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.